Humana Inc. (NYSE:HUM) closed its last session at $158.15 with the change of -2.82%. The market capitalization of the company is $23.57B with an average Volume of 1.38 million shares. The stock currently has its 52-Week High range of $192.49 and 52-week low range of $155.24. The Price to Book (P/B) ratio stands at 2.30. The stock traded total quantity of 5.57 million shares.
For the current Fiscal Quarter, 19 analysts have given an average earnings per share forecast of $2.19. The Low Earnings per share estimate of the current Quarter is $2.15 and High Estimate is set at $2.25 according to these Analysts opinions. The Previous Year EPS of this Quarter is $1.67.
According to 14 analysts, an average sales Estimate of the current Fiscal quarter is $13.60B. The lower sales estimate is $13.20B and higher sales estimate is $13.82B according to these Analysts thoughts.
The Company currently has Highest Price Target of $244 and Lowest Price Target of $180. It has Median Price Targets of $216. Mean price target is set at $211.38 after consensus analysis of 13 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month 3 analysts have assigned this stock as Strong Buy where 3 assigned Buy, 12 analysts believe it’s a Hold, 0 said Underperform and 0 assigned Sell rating.
Edwards Lifesciences Corporation (NYSE:EW) ended its last trade at $104.72 with the move of +0.93%. The company has market value of $22.18B with the total traded volume of 1.33 million. The stock currently has its 52-Week top value of $112.00 and 52-week down value of $62.53. The price to book (P/B) ratio of the company is 9.56. Its previous closing price was recorded at $103.75.
For the current Fiscal Quarter, 25 analysts have given an Average earnings estimate of $0.7 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $0.68 while High Estimate is $0.72. The Previous Year EPS of this Quarter is $0.57.
According to 23 analysts, an Average Revenue Estimate of the current Fiscal quarter is $722.66M. According to them, the Low Revenue estimate is $682.30M and High Revenue estimate is $737.15M.
The Company currently has High Price Target of $135. The Low and Mean Price Targets are $86 and $117.59 respectively. These price targets are set after consensus analysis of 22 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month, 7 analysts have given this stock as Strong Buy where 11 issued Buy, 6 analysts think that it’s a Hold, 0 told Underperform and1 assigned Sell rating.